Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 196

1.

Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms.

Anderson LT, Campbell M, Grega DM, Perry R, Small AM, Green WH.

Am J Psychiatry. 1984 Oct;141(10):1195-202.

PMID:
6385731
[PubMed - indexed for MEDLINE]
2.

The effects of haloperidol on learning and behavior in autistic children.

Campbell M, Anderson LT, Small AM, Perry R, Green WH, Caplan R.

J Autism Dev Disord. 1982 Jun;12(2):167-75.

PMID:
7174605
[PubMed - indexed for MEDLINE]
3.

The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children.

Anderson LT, Campbell M, Adams P, Small AM, Perry R, Shell J.

J Autism Dev Disord. 1989 Jun;19(2):227-39.

PMID:
2663834
[PubMed - indexed for MEDLINE]
4.

Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.

Akhondzadeh S, Erfani S, Mohammadi MR, Tehrani-Doost M, Amini H, Gudarzi SS, Yasamy MT.

J Clin Pharm Ther. 2004 Apr;29(2):145-50.

PMID:
15068403
[PubMed - indexed for MEDLINE]
5.

A study of haloperidol in young autistic children: a within-subjects design using objective rating scales.

Cohen IL, Campbell M, Posner D.

Psychopharmacol Bull. 1980 Jul;16(3):63-5. No abstract available.

PMID:
7403407
[PubMed - indexed for MEDLINE]
6.

Naltrexone in autistic children: behavioral symptoms and attentional learning.

Campbell M, Anderson LT, Small AM, Adams P, Gonzalez NM, Ernst M.

J Am Acad Child Adolesc Psychiatry. 1993 Nov;32(6):1283-91.

PMID:
8282676
[PubMed - indexed for MEDLINE]
7.

Clomipramine versus haloperidol in the treatment of autistic disorder: a double-blind, placebo-controlled, crossover study.

Remington G, Sloman L, Konstantareas M, Parker K, Gow R.

J Clin Psychopharmacol. 2001 Aug;21(4):440-4.

PMID:
11476129
[PubMed - indexed for MEDLINE]
8.

Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder.

Campbell M, Small AM, Green WH, Jennings SJ, Perry R, Bennett WG, Anderson L.

Arch Gen Psychiatry. 1984 Jul;41(7):650-6.

PMID:
6428371
[PubMed - indexed for MEDLINE]
9.

Comparison of long-term efficacy and safety of risperidone and haloperidol in children and adolescents with autistic disorder. An open label maintenance study.

Gencer O, Emiroglu FN, Miral S, Baykara B, Baykara A, Dirik E.

Eur Child Adolesc Psychiatry. 2008 Jun;17(4):217-25.

PMID:
18026891
[PubMed - indexed for MEDLINE]
10.

A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism.

Fankhauser MP, Karumanchi VC, German ML, Yates A, Karumanchi SD.

J Clin Psychiatry. 1992 Mar;53(3):77-82.

PMID:
1548248
[PubMed - indexed for MEDLINE]
11.

Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study.

Silver AA, Shytle RD, Philipp MK, Wilkinson BJ, McConville B, Sanberg PR.

J Clin Psychiatry. 2001 Sep;62(9):707-14.

PMID:
11681767
[PubMed - indexed for MEDLINE]
12.

Tetrahydrobiopterin in the treatment of children with autistic disorder: a double-blind placebo-controlled crossover study.

Danfors T, von Knorring AL, Hartvig P, Langstrom B, Moulder R, Stromberg B, Torstenson R, Wester U, Watanabe Y, Eeg-Olofsson O.

J Clin Psychopharmacol. 2005 Oct;25(5):485-9.

PMID:
16160627
[PubMed - indexed for MEDLINE]
13.

Differential response of seven subjects with autistic disorder to clomipramine and desipramine.

Gordon CT, Rapoport JL, Hamburger SD, State RC, Mannheim GB.

Am J Psychiatry. 1992 Mar;149(3):363-6.

PMID:
1536276
[PubMed - indexed for MEDLINE]
14.

Risperidone: new indication. Behavioural disorders in children with autism or mental disabilities: no progress.

[No authors listed]

Prescrire Int. 2006 Apr;15(82):43-5.

PMID:
16602211
[PubMed - indexed for MEDLINE]
15.

Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.

Wasserman S, Iyengar R, Chaplin WF, Watner D, Waldoks SE, Anagnostou E, Soorya L, Hollander E.

Int Clin Psychopharmacol. 2006 Nov;21(6):363-7.

PMID:
17012983
[PubMed - indexed for MEDLINE]
16.

Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies.

Willemsen-Swinkels SH, Buitelaar JK, Nijhof GJ, van England H.

Arch Gen Psychiatry. 1995 Sep;52(9):766-73.

PMID:
7654128
[PubMed - indexed for MEDLINE]
17.

A comparison of live and videotape ratings: clomipramine and haloperidol in autism.

Sanchez LE, Adams PB, Uysal S, Hallin A, Campbell M, Small AM.

Psychopharmacol Bull. 1995;31(2):371-8.

PMID:
7491394
[PubMed - indexed for MEDLINE]
18.

A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.

Gordon CT, State RC, Nelson JE, Hamburger SD, Rapoport JL.

Arch Gen Psychiatry. 1993 Jun;50(6):441-7.

PMID:
8498878
[PubMed - indexed for MEDLINE]
19.

Effects of intravenous secretin on language and behavior of children with autism and gastrointestinal symptoms: a single-blinded, open-label pilot study.

Lightdale JR, Hayer C, Duer A, Lind-White C, Jenkins S, Siegel B, Elliott GR, Heyman MB.

Pediatrics. 2001 Nov;108(5):E90.

PMID:
11694674
[PubMed - indexed for MEDLINE]
20.

Factors related to haloperidol response and dyskinesias in autistic children.

Locascio JJ, Malone RP, Small AM, Kafantaris V, Ernst M, Lynch NS, Overall JE, Campbell M.

Psychopharmacol Bull. 1991;27(2):119-26.

PMID:
1924657
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk